Sarepta Therapeutics (SRPT) Revenue Growth (1y) (2011 - 2026)
Sarepta Therapeutics (SRPT) Revenue Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.72 Bn | - | - |
| 3 | Akari Therapeutics | 1,045.06 Bn | 1,045.06 Bn | - | - |
| 4 | BeOne Medicines | 470.64 Bn | 465.84 Bn | 1.35 Bn | 35.46% |
| 5 | Vertex Pharmaceuticals | 122.91 Bn | 115.67 Bn | 2.59 Bn | 7.82% |
| 6 | Regeneron Pharmaceuticals | 70.07 Bn | 61.31 Bn | 3.31 Bn | 19.04% |
| 7 | Belite Bio | 62.77 Bn | 62.77 Bn | - | - |
| 8 | Argenx Se | 56.21 Bn | 51.02 Bn | 1.41 Bn | 64.03% |
| 9 | Revolution Medicines | 37.60 Bn | 37.60 Bn | - | - |
| 10 | Sarepta Therapeutics | 1.71 Bn | 1.31 Bn | 622.04 Mn | 448.10% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 448.10% |
| Dec 31, 2025 | -32.73% |
| Sep 30, 2025 | -14.52% |
| Jun 30, 2025 | 68.38% |
| Mar 31, 2025 | -67.75% |
| Dec 31, 2024 | -38.93% |
| Sep 30, 2024 | 51.03% |
| Jun 30, 2024 | 38.93% |
| Mar 31, 2024 | 78.61% |
| Dec 31, 2023 | 24.46% |
| Sep 30, 2023 | 34.33% |
| Jun 30, 2023 | 23.67% |
| Mar 31, 2023 | 22.61% |
| Dec 31, 2022 | 384.69% |
| Sep 30, 2022 | 923.65% |
| Jun 30, 2022 | 28.73% |
| Mar 31, 2022 | 28.50% |
| Dec 31, 2021 | 23.14% |
| Sep 30, 2021 | -81.47% |
| Jun 30, 2021 | 19.46% |